Lumosa Therapeutics Co., Ltd. (TPEX:6535)

Taiwan · Delayed Price · Currency is TWD

179.00

+0.50 (0.28%)

At close: Feb 11, 2026

Revenue by Segment

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015
Biotechnology	39.15M	56.92M	26.64M	17.36M	21.65M
Biotechnology Growth	-31.21%	113.63%	53.45%	-19.81%	-87.42%
Total	39.15M	56.92M	26.64M	17.36M	21.65M
Total Growth	-31.21%	113.63%	53.45%	-19.81%	-87.42%

Revenue by Geography

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015
Asia	11.65M	25.61M	2.00M	2.33M	2.00M
Asia Growth	-54.52%	1180.25%	-14.02%	16.30%	-98.73%
Taiwan	27.33M	15.41M	21.24M	15.04M	19.65M
Taiwan Growth	77.34%	-27.46%	41.27%	-23.48%	30.39%
America	182.00K	7.56M	3.19M	-	-
America Growth	-97.59%	137.01%	-	-	-
Europe	-	8.35M	213.00K	-	-
Europe Growth	-	3818.31%	-	-	-
Total	39.15M	56.92M	26.64M	17.36M	21.65M
Total Growth	-31.21%	113.63%	53.45%	-19.81%	-87.42%

Source: S&P Global Market Intelligence.